BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,050 filers reported holding BAXTER INTL INC in Q4 2018. The put-call ratio across all filers is 0.81 and the average weighting 0.3%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2024 | $74 | -92.6% | 1,727 | +43075.0% | 0.01% | – |
Q2 2020 | $1,000 | -99.9% | 4 | -100.0% | 0.00% | -100.0% |
Q2 2019 | $685,000 | +31.2% | 8,364 | +5.5% | 0.15% | +10.4% |
Q4 2018 | $522,000 | -15.4% | 7,930 | -0.9% | 0.13% | +2.3% |
Q3 2018 | $617,000 | +1.0% | 8,004 | -3.2% | 0.13% | -3.0% |
Q2 2018 | $611,000 | -82.5% | 8,267 | -84.6% | 0.14% | -73.7% |
Q1 2018 | $3,484,000 | -2.0% | 53,567 | -2.6% | 0.51% | +9.4% |
Q4 2017 | $3,554,000 | +1.3% | 54,971 | -1.6% | 0.47% | +8.5% |
Q3 2017 | $3,507,000 | +23.4% | 55,887 | +2.0% | 0.43% | +27.4% |
Q1 2017 | $2,841,000 | +16.5% | 54,780 | -0.4% | 0.34% | +16.8% |
Q4 2016 | $2,439,000 | +1.1% | 54,990 | +8.5% | 0.29% | +11.1% |
Q3 2016 | $2,412,000 | +15.1% | 50,666 | +9.3% | 0.26% | +24.2% |
Q2 2016 | $2,096,000 | +1.6% | 46,348 | -7.7% | 0.21% | +21.3% |
Q1 2016 | $2,063,000 | +156.0% | 50,217 | +137.8% | 0.17% | +194.9% |
Q4 2015 | $806,000 | +23.1% | 21,114 | +5.9% | 0.06% | +11.3% |
Q3 2015 | $655,000 | -52.3% | 19,930 | +1.5% | 0.05% | -45.9% |
Q2 2015 | $1,373,000 | +7.3% | 19,634 | +5.2% | 0.10% | +10.1% |
Q1 2015 | $1,279,000 | +7.0% | 18,672 | +14.5% | 0.09% | -5.3% |
Q4 2014 | $1,195,000 | -29.7% | 16,305 | -31.2% | 0.09% | -39.0% |
Q3 2014 | $1,701,000 | +0.7% | 23,690 | +1.4% | 0.15% | +4.8% |
Q2 2014 | $1,690,000 | +2.7% | 23,370 | +4.6% | 0.15% | -9.8% |
Q1 2014 | $1,645,000 | +54733.3% | 22,348 | +61977.8% | 0.16% | – |
Q4 2013 | $3,000 | 0.0% | 36 | 0.0% | 0.00% | – |
Q3 2013 | $3,000 | 0.0% | 36 | 0.0% | 0.00% | – |
Q2 2013 | $3,000 | – | 36 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Soditic Asset Management LLP | 147,620 | $7,951,000 | 9.91% |
NUANCE INVESTMENTS, LLC | 5,429,702 | $292,444,000 | 6.51% |
Endurant Capital Management LP | 245,093 | $13,201,000 | 4.30% |
Veritas Asset Management LLP | 8,589,401 | $462,625,000 | 3.83% |
GENERATION INVESTMENT MANAGEMENT LLP | 11,876,040 | $639,644,000 | 3.80% |
Sivik Global Healthcare LLC | 120,000 | $6,463,000 | 3.59% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 480,500 | $25,880,000 | 3.31% |
Integral Health Asset Management, LLC | 300,000 | $16,158,000 | 3.14% |
Boothe Investment Group, Inc. | 89,078 | $4,798,000 | 3.11% |
Glenview Capital Management | 2,257,019 | $121,563,000 | 3.04% |